【著書】 1. 秋野公造. 健康ニッポンを造る.潮出版社,東京,2010.(ISBN9784267018411) 2. 寺本明,山下俊一,秋野公造,太組一朗. 神経解剖集中講義,第2版,医学書院,東京,2012:1-211.(ISBN9784260014915) 3. 浅香正博,秋野公造. 胃がんは「ピロリ菌除菌」でなくせる.潮出版社,東京,2013:1-212.(ISBN9784267019586) 4. 秋野公造. 明日の「健康ニッポン」を造る.潮出版社,東京,2016.(ISBN9784267020438) 5. 溝口偦,秋野公造. 世界を変えるCode-EX: 次世代コードで多言語・情報革命を実現.第三文明社, 東京,2016:1-162.(ISBN9784476033533) 6. 大浦武彦,秋野公造. 糖尿病・透析の人に役立つ―「足病」の教科書.三五館,東京,2016:1-219.(ISBN9784883206681) 7. 小林修三,秋野公造. フットケアで寿命を延ばす.PHPエディターズ・グループ,東京,2017:1-207.(ISBN9784909417008) 8. 大澤真木子,秋野公造. てんかんの教科書.メディカルレビュー社,東京,2017:1-181.(ISBN9784779219818) 9. 臼井明,守屋進,秋野公造. たった1つの選択で日本は変えられる.総合法令出版,東京,2017:1-200.(ISBN9784862805812) 10. 中元秀友,秋野公造. やさしい腎代替療法. 西村書店,東京,2018:1-211.(ISBN9784890137916) 11. 秋野公造,屋比久勝子. これからの「新しい栄養学」について語りましょう.現代書林,東京,2019:1-247.(ISBN9784774517551) 12. 中元秀友,秋野公造. 腎代替療法の未来. 西村書店,東京,2020:1-263.(ISBN9784867060100) 【論文】 1. Akino K, Tanigawa K, Shibata H, Nakamura T, Nagataki S, Yamashita S. Time to consider additional diagnostic criteria for HTLV-I-associated myelopathy?. THE LANCET 1995;345(8964):1570. 2. Akino K, Ohtsuru A, Yano H, Ozeki S, Namba H, Nakashima M, Ito M,Matsumoto T, and Yamashita S. Antisense inhibition of parathyroid hormone-related peptidegene expression reduces malignant pituitary tumor progression and metastases in the rat. CANCER RESEARCH 1996;56(1):7-86. 3. Naito S, Shimizu K, Akino K, Ohtsuru A, Watanabe M, Yamashita S, Sekine I. Autocrine/paracrine involvement of parathyroid hormone-related peptide in vascular leiomyoma. Endocr J 2002;49(3):335-341. 4. Akino K, Mineta T, Fukui M, Fujii T, Akita S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells.Wound Repair Regen 2003;11(5):354-360. 5. Akita S, Fukui M, Nakagawa H, Fujii T, Akino K. Cranial bone defect healing is accelerated by mesenchymal stem cells induced by co-administration of bone morphogenetic protein-2 and basic fibroblast growth factor.Wound Repair Regen 2004;12(2):252-259. 6. Akita S, Daian T, Ishihara H, Fujii T,Akino K. Leukemia inhibitory factor-transfected embryonic fibroblasts and vascular endothelial growth factor successfully improve the skin substitute wound healing by increasing angiogenesis and matrix production.J Dermatol Sci2004;36(1):11-23. 7. Akino K, Akita S, Mizuguchi T, Takumi I, Yu R, Wang XY, Rozga J, Demetriou AA, Melmed S, Ohtsuru A, Yamashita S. A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration.J Surg Res2005;129(1):142-146. 8. Fukui M, Akita S,Akino K. Ectopic bone formation facilitated by human mesenchymal stem cells and osteogenic cytokines via nutrient vessel injection in a nude rat model.Wound Repair Regen 2005;13(3):332-430. 9. Akita S,Akino K, Imaizumi T, Hirano A. A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns 2005;31(7):855-858. 10. Akita S,Akino K, Ren SG, Melmed S, Imaizumi T, Hirano A. Elevated circulating leukemia inhibitory factor in patients with extensive burns. J Burn Care Res 2006;27(2):221-225. 11. Akita S,Akino K, Imaizumi T, Tanaka K, Anraku K, Yano H, Hirano A. A polyurethane dressing is beneficial for split-thickness skin-graft donor wound healing.Burns 2006;32(4):447-451. 12. Akita S, Akino K, Imaizumi T, Tanaka K, Anraku K, Yano H, Hirano A. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor.J Burn Care Res 2006;27(3):333-338. 13. Akino K, Mineda T, Mori N, Hirano A, Imaizumi T, Akita S. Attenuation of cysteinyl leukotrienes induces human mesenchymal stem cell differentiation.Wound Repair Regen 2006;14(3):343-349. 14. Akita S,Akino K, Tanaka K, Anraku K, Yano H, Hirano A. Therapeutic choice for craniofacial venous malformations.J Craniofac Surg 2006;17(4):729-735. 15. Imaizumi T, Akita S, Akino K, Hirano A. Acceleration of sensory neural regeneration and wound healing with human mesenchymal stem cells in immunodeficient rats.Stem Cells 2007;25(11):2956-2963. 16. Akita S, Akino K, Yakabe A, Imaizumi T, Tanaka K, Anraku K, Yano H, Hirano A. Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg 2007;18(5):1164-1169. 17. Akita S, Akino K, Tanaka K, Anraku K, Hirano A. A basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute.J Trauma 2008;64(3):809-815. doi:10.1097/TA.0b013e31802c8247. 18. Akino K, Akita S, Yakabe A, Mineda T, Hayashi T, Hirano A. Human mesenchymal stem cells may be involved in keloid pathogenesis.Int J Dermatol 2008;47(11):1112-1117. doi:10.1111/j.1365-4632.2008.03380.x. 19. Akita S, Akino K, Imaizumi T, Hirano A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing.Wound Repair Regen 2008;16(5):635-641. doi:10.1111/j.1524-475X.2008.00414.x. 20. Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S. Mesenchymal stem cell therapy for cutaneous radiation syndrome.Health Phys 2010;98(6):858-862. doi:10.1097/HP.0b013e3181d3d52c. 21. Akita S,Akino K, Yakabe A, Tanaka K, Anraku K, Yano H, Hirano A. Basic fibroblast growth factor is beneficial for postoperative color uniformity in split-thickness skin grafting.WoundRepairRegen2010;18(6):560-566.doi:10.1111/j.1524-475X.2010.00620.x.PMID: 20868384 22. Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S. Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury.Stem Cells Int 2010:532704. doi:10.4061/2010/532704. 23. Akita S, Yoshimoto H, Akino K, Ohtsuru A, Hayashida K, Hirano A, Suzuki K, Yamashita S. Early experiences with stem cells in treating chronic wounds. Clin Plast Surg 2012;39(3):281-292. doi:10.1016/j.cps.2012.04.005. 24. Akita S, Akino K, Hirano A. Basic Fibroblast Growth Factor in Scarless Wound Healing.Adv Wound Care (New Rochelle). 2013;2(2):44-49. 【総説・解説】 1. 秋野公造. エイズ予防指針改正後のエイズ対策について.保健医療科学 2007;56(3):178-185. 2. 秋野公造. 胃がん撲滅に対する公明党の取り組み.THE GI Forefront 2012;8(2):33-36. 3. 浅香正博,秋野公造. 世界に誇れる胃癌対策-医療と政策の関わり.Frontiers in Gastroenterology 2013;18(3):193-202. 4. 秋野公造. 生殖補助医療の法制化に向けた取り組み~生殖補助医療の適切な提供の確保に関する法律案.日本医師会雑誌2015;144(2):293-296. |